Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Or Refractory Multiple Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00293111
What this trial is testing

Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Cephalon 30
Testing effectiveness (Phase 2)Study completedNCT00410605
What this trial is testing

Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseStage II Multiple MyelomaStage III Multiple Myeloma
National Cancer Institute (NCI) 39
Very early researchLooking for participantsNCT06718270
What this trial is testing

CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia

Who this might be right for
Relapsed/Refractory Multiple MyelomaRelapsed/Refractory Plasma Cell Leukemia
Shanghai Changzheng Hospital 24
Testing effectiveness (Phase 2)Looking for participantsNCT05565807
What this trial is testing

Safety and Efficacy Study of An Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Zhejiang ACEA Pharmaceutical Co. Ltd. 84
Not applicableUnknownNCT03380039
What this trial is testing

Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma

Who this might be right for
Refractory or Relapsed Multiple Myeloma
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 6
Not applicableApproved For MarketingNCT05164250
What this trial is testing

Compassionate Use (CU) of REGN5458 for Patients With Relapsed or Refractory Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Regeneron Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01632150
What this trial is testing

Safety Study of Elotuzumab in Combination With Thalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Relapsed and/or Refractory Multiple Myeloma
Bristol-Myers Squibb 51
Early research (Phase 1)Study completedNCT00568880
What this trial is testing

Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Abramson Cancer Center at Penn Medicine 25
Early research (Phase 1)Active Not RecruitingNCT05020444
What this trial is testing

TriPRIL CAR T Cells in Multiple Myeloma

Who this might be right for
Multiple MyelomaMultiple Myeloma in RelapseRefractory Multiple Myeloma
Marcela V. Maus, M.D.,Ph.D. 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT03715478
What this trial is testing

Multi-Center Study of GSK2857916 in Combination With Pomalidomide and Dex

Who this might be right for
Relapsed and/or Refractory Multiple Myeloma
Canadian Myeloma Research Group 120
Early research (Phase 1)Looking for participantsNCT06508463
What this trial is testing

Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T Cell LymphomaRelapsed Peripheral T-Cell LymphomaPeripheral T-Cell Lymphoma, Not Otherwise Specified+4 more
Mayo Clinic 21
Early research (Phase 1)Study completedNCT01689987
What this trial is testing

Hydroxychloroquine, Cyclophosphamide, Dexamethasone, and Sirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
OHSU Knight Cancer Institute 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT03915184
What this trial is testing

Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)

Who this might be right for
Multiple Myeloma
CARsgen Therapeutics Co., Ltd. 105
Testing effectiveness (Phase 2)Study completedNCT01177735
What this trial is testing

Pomalidomide in Gene Expression Profiling (GEP)-Defined High-risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 71
Early research (Phase 1)Not Yet RecruitingNCT07611149
What this trial is testing

Study to Evaluate the Safety of UF-KURE-BCMA CAR T-Cells in Advanced Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
Kure Cells, INC 12
Testing effectiveness (Phase 2)WithdrawnNCT05408026
What this trial is testing

Study of Combination POM, BTZ, Low-Dose DEX, and DARA (PVD-DARA) in Patients With RRMM

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Alliance Foundation Trials, LLC.
Large-scale testing (Phase 3)Study completedNCT00813150
What this trial is testing

Study of Bortezomib and Dexamethasone With or Without Cyclophosphamide in Patients With Relapsed or Not Controllable Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen-Cilag G.m.b.H 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT05514990
What this trial is testing

Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or Refractory Multiple Myeloma, AMBUSH Trial

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
University of Southern California 10
Very early researchLooking for participantsNCT07771803
What this trial is testing

A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)

Who this might be right for
AML (Acute Myeloid Leukemia)Multiple Myeloma Refractory
Roger Strair 20
Next Page